Eplontersen for hereditary transthyretin amyloidosis with polyneuropathy
It is injected subcutaneously and is not insulin, and it is not for type 1 diabetes or diabetic ketoacidosis
Other side effects can include dizziness, mild tachycardia (increased heart rate), infections, headaches and indigestion
Results showed that semaglutide 1.0 mg once weekly produced superior HbA1c reductions (mean decrease of 1.5% from baseline) compared to exenatide, with patients also experiencing greater weight loss (average 5.6 kg over 56 weeks)
They reduce LDL, stabilize plaque, and cost a fraction of GLP 1s Maybe the move here is a low dose statin + low dose GLP-1
BPC-157 (0.5mg/capsule), 60 Capsules Same Trusted Formula